1 Guidance

1 Guidance

1.1 Current evidence on the safety and efficacy of percutaneous mitral valve annuloplasty is inadequate in quality and quantity. Therefore this procedure should only be used in the context of research, which should clearly describe patient selection, concomitant medical therapies and safety outcomes. Both objective measurements and clinical outcomes should be reported.

1.2 Percutaneous mitral valve annuloplasty should only be carried out by interventional cardiologists with specific training in the procedure.

1.3 NICE may review the procedure on publication of further evidence.

  • National Institute for Health and Care Excellence (NICE)